0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Dry Eye Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-119
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dry Eye Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Dry Eye Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-119
Report
April 2024
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dry Eye Drugs - Market Size

The global market for Dry Eye Drugs was estimated to be worth US$ 8579 million in 2023 and is forecast to a readjusted size of US$ 19140 million by 2030 with a CAGR of 12.0% during the forecast period 2024-2030

Dry Eye Drugs - Market

Dry Eye Drugs - Market

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Global Dry Eye Drugs key players include Novartis AG, Valeant Pharmaceuticals, Allergan, Johnson & Johnson, Santen Pharma, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 40%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.
In terms of product, Artificial Tears is the largest segment, with a share over 85%. And in terms of application, the largest application is Hospital, followed by Drug Stores, Online Pharmacies.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dry Eye Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dry Eye Drugs by region & country, by Type, and by Application.
The Dry Eye Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Drugs.
Market Segmentation

Scope of Dry Eye Drugs - Market Report

Report Metric Details
Report Name Dry Eye Drugs - Market
Forecasted market size in 2030 US$ 19140 million
CAGR 12.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Artificial Tears
  • Anti-inflammatory Drugs
  • Other
Segment by Application
  • Hospital
  • Drug Stores
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Allergan, Novartis AG, Bausch Health, Santen Pharma, Takeda, Johnson & Johnson, United Laboratories, Senju Pharmaceutical, Jianfeng Group, Eusan GMBH
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Dry Eye Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Dry Eye Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Dry Eye Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Dry Eye Drugs - Market size in 2030?

Ans: The Dry Eye Drugs - Market size in 2030 will be US$ 19140 million.

What is the market share of major companies in Dry Eye Drugs - Market?

Ans: Global top five manufacturers hold a share about 75%.

What is the Dry Eye Drugs - Market share by type?

Ans: In terms of product, Artificial Tears is the largest segment, with a share over 85%.

Who are the main players in the Dry Eye Drugs - Market report?

Ans: The main players in the Dry Eye Drugs - Market are Allergan, Novartis AG, Bausch Health, Santen Pharma, Takeda, Johnson & Johnson, United Laboratories, Senju Pharmaceutical, Jianfeng Group, Eusan GMBH

What are the Application segmentation covered in the Dry Eye Drugs - Market report?

Ans: The Applications covered in the Dry Eye Drugs - Market report are Hospital, Drug Stores, Online Pharmacies

What are the Type segmentation covered in the Dry Eye Drugs - Market report?

Ans: The Types covered in the Dry Eye Drugs - Market report are Artificial Tears, Anti-inflammatory Drugs, Other

1 Market Overview
1.1 Dry Eye Drugs Product Introduction
1.2 Global Dry Eye Drugs Market Size Forecast
1.2.1 Global Dry Eye Drugs Sales Value (2019-2030)
1.2.2 Global Dry Eye Drugs Sales Volume (2019-2030)
1.2.3 Global Dry Eye Drugs Sales Price (2019-2030)
1.3 Dry Eye Drugs Market Trends & Drivers
1.3.1 Dry Eye Drugs Industry Trends
1.3.2 Dry Eye Drugs Market Drivers & Opportunity
1.3.3 Dry Eye Drugs Market Challenges
1.3.4 Dry Eye Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dry Eye Drugs Players Revenue Ranking (2023)
2.2 Global Dry Eye Drugs Revenue by Company (2019-2024)
2.3 Global Dry Eye Drugs Players Sales Volume Ranking (2023)
2.4 Global Dry Eye Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Dry Eye Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Dry Eye Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Dry Eye Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dry Eye Drugs
2.9 Dry Eye Drugs Market Competitive Analysis
2.9.1 Dry Eye Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Dry Eye Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Artificial Tears
3.1.2 Anti-inflammatory Drugs
3.1.3 Other
3.2 Global Dry Eye Drugs Sales Value by Type
3.2.1 Global Dry Eye Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dry Eye Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Dry Eye Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Dry Eye Drugs Sales Volume by Type
3.3.1 Global Dry Eye Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Dry Eye Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Dry Eye Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Dry Eye Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Drug Stores
4.1.3 Online Pharmacies
4.2 Global Dry Eye Drugs Sales Value by Application
4.2.1 Global Dry Eye Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dry Eye Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Dry Eye Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Dry Eye Drugs Sales Volume by Application
4.3.1 Global Dry Eye Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Dry Eye Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Dry Eye Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Dry Eye Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Dry Eye Drugs Sales Value by Region
5.1.1 Global Dry Eye Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dry Eye Drugs Sales Value by Region (2019-2024)
5.1.3 Global Dry Eye Drugs Sales Value by Region (2025-2030)
5.1.4 Global Dry Eye Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Dry Eye Drugs Sales Volume by Region
5.2.1 Global Dry Eye Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Dry Eye Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Dry Eye Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Dry Eye Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Dry Eye Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Dry Eye Drugs Sales Value, 2019-2030
5.4.2 North America Dry Eye Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Dry Eye Drugs Sales Value, 2019-2030
5.5.2 Europe Dry Eye Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Dry Eye Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Dry Eye Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Dry Eye Drugs Sales Value, 2019-2030
5.7.2 South America Dry Eye Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dry Eye Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Dry Eye Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dry Eye Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dry Eye Drugs Sales Value
6.2.1 Key Countries/Regions Dry Eye Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Dry Eye Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Dry Eye Drugs Sales Value, 2019-2030
6.3.2 United States Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dry Eye Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dry Eye Drugs Sales Value, 2019-2030
6.4.2 Europe Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dry Eye Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dry Eye Drugs Sales Value, 2019-2030
6.5.2 China Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dry Eye Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dry Eye Drugs Sales Value, 2019-2030
6.6.2 Japan Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dry Eye Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dry Eye Drugs Sales Value, 2019-2030
6.7.2 South Korea Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dry Eye Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dry Eye Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dry Eye Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dry Eye Drugs Sales Value, 2019-2030
6.9.2 India Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dry Eye Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Company Information
7.1.2 Allergan Introduction and Business Overview
7.1.3 Allergan Dry Eye Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Allergan Dry Eye Drugs Product Offerings
7.1.5 Allergan Recent Development
7.2 Novartis AG
7.2.1 Novartis AG Company Information
7.2.2 Novartis AG Introduction and Business Overview
7.2.3 Novartis AG Dry Eye Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Novartis AG Dry Eye Drugs Product Offerings
7.2.5 Novartis AG Recent Development
7.3 Bausch Health
7.3.1 Bausch Health Company Information
7.3.2 Bausch Health Introduction and Business Overview
7.3.3 Bausch Health Dry Eye Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bausch Health Dry Eye Drugs Product Offerings
7.3.5 Bausch Health Recent Development
7.4 Santen Pharma
7.4.1 Santen Pharma Company Information
7.4.2 Santen Pharma Introduction and Business Overview
7.4.3 Santen Pharma Dry Eye Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Santen Pharma Dry Eye Drugs Product Offerings
7.4.5 Santen Pharma Recent Development
7.5 Takeda
7.5.1 Takeda Company Information
7.5.2 Takeda Introduction and Business Overview
7.5.3 Takeda Dry Eye Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Takeda Dry Eye Drugs Product Offerings
7.5.5 Takeda Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Information
7.6.2 Johnson & Johnson Introduction and Business Overview
7.6.3 Johnson & Johnson Dry Eye Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Johnson & Johnson Dry Eye Drugs Product Offerings
7.6.5 Johnson & Johnson Recent Development
7.7 United Laboratories
7.7.1 United Laboratories Company Information
7.7.2 United Laboratories Introduction and Business Overview
7.7.3 United Laboratories Dry Eye Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 United Laboratories Dry Eye Drugs Product Offerings
7.7.5 United Laboratories Recent Development
7.8 Senju Pharmaceutical
7.8.1 Senju Pharmaceutical Company Information
7.8.2 Senju Pharmaceutical Introduction and Business Overview
7.8.3 Senju Pharmaceutical Dry Eye Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Senju Pharmaceutical Dry Eye Drugs Product Offerings
7.8.5 Senju Pharmaceutical Recent Development
7.9 Jianfeng Group
7.9.1 Jianfeng Group Company Information
7.9.2 Jianfeng Group Introduction and Business Overview
7.9.3 Jianfeng Group Dry Eye Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Jianfeng Group Dry Eye Drugs Product Offerings
7.9.5 Jianfeng Group Recent Development
7.10 Eusan GMBH
7.10.1 Eusan GMBH Company Information
7.10.2 Eusan GMBH Introduction and Business Overview
7.10.3 Eusan GMBH Dry Eye Drugs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Eusan GMBH Dry Eye Drugs Product Offerings
7.10.5 Eusan GMBH Recent Development
8 Industry Chain Analysis
8.1 Dry Eye Drugs Industrial Chain
8.2 Dry Eye Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dry Eye Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Dry Eye Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Dry Eye Drugs Market Trends
    Table 2. Dry Eye Drugs Market Drivers & Opportunity
    Table 3. Dry Eye Drugs Market Challenges
    Table 4. Dry Eye Drugs Market Restraints
    Table 5. Global Dry Eye Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Dry Eye Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Dry Eye Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Dry Eye Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Dry Eye Drugs Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Dry Eye Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Dry Eye Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Dry Eye Drugs
    Table 13. Global Dry Eye Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Dry Eye Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Dry Eye Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Dry Eye Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Dry Eye Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Dry Eye Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Dry Eye Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Dry Eye Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Dry Eye Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Dry Eye Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Dry Eye Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Dry Eye Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Dry Eye Drugs Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Dry Eye Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Dry Eye Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Dry Eye Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Dry Eye Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Dry Eye Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Dry Eye Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Dry Eye Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Dry Eye Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Dry Eye Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Dry Eye Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Dry Eye Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Dry Eye Drugs Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Dry Eye Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Dry Eye Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Dry Eye Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Dry Eye Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Dry Eye Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Dry Eye Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Dry Eye Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Dry Eye Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Dry Eye Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Dry Eye Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Dry Eye Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Dry Eye Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Dry Eye Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Dry Eye Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Dry Eye Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Dry Eye Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Dry Eye Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Allergan Company Information
    Table 58. Allergan Introduction and Business Overview
    Table 59. Allergan Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Allergan Dry Eye Drugs Product Offerings
    Table 61. Allergan Recent Development
    Table 62. Novartis AG Company Information
    Table 63. Novartis AG Introduction and Business Overview
    Table 64. Novartis AG Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Novartis AG Dry Eye Drugs Product Offerings
    Table 66. Novartis AG Recent Development
    Table 67. Bausch Health Company Information
    Table 68. Bausch Health Introduction and Business Overview
    Table 69. Bausch Health Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Bausch Health Dry Eye Drugs Product Offerings
    Table 71. Bausch Health Recent Development
    Table 72. Santen Pharma Company Information
    Table 73. Santen Pharma Introduction and Business Overview
    Table 74. Santen Pharma Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Santen Pharma Dry Eye Drugs Product Offerings
    Table 76. Santen Pharma Recent Development
    Table 77. Takeda Company Information
    Table 78. Takeda Introduction and Business Overview
    Table 79. Takeda Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Takeda Dry Eye Drugs Product Offerings
    Table 81. Takeda Recent Development
    Table 82. Johnson & Johnson Company Information
    Table 83. Johnson & Johnson Introduction and Business Overview
    Table 84. Johnson & Johnson Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Johnson & Johnson Dry Eye Drugs Product Offerings
    Table 86. Johnson & Johnson Recent Development
    Table 87. United Laboratories Company Information
    Table 88. United Laboratories Introduction and Business Overview
    Table 89. United Laboratories Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. United Laboratories Dry Eye Drugs Product Offerings
    Table 91. United Laboratories Recent Development
    Table 92. Senju Pharmaceutical Company Information
    Table 93. Senju Pharmaceutical Introduction and Business Overview
    Table 94. Senju Pharmaceutical Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Senju Pharmaceutical Dry Eye Drugs Product Offerings
    Table 96. Senju Pharmaceutical Recent Development
    Table 97. Jianfeng Group Company Information
    Table 98. Jianfeng Group Introduction and Business Overview
    Table 99. Jianfeng Group Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Jianfeng Group Dry Eye Drugs Product Offerings
    Table 101. Jianfeng Group Recent Development
    Table 102. Eusan GMBH Company Information
    Table 103. Eusan GMBH Introduction and Business Overview
    Table 104. Eusan GMBH Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Eusan GMBH Dry Eye Drugs Product Offerings
    Table 106. Eusan GMBH Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Dry Eye Drugs Downstream Customers
    Table 110. Dry Eye Drugs Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dry Eye Drugs Product Picture
    Figure 2. Global Dry Eye Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Dry Eye Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Dry Eye Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Dry Eye Drugs Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Dry Eye Drugs Report Years Considered
    Figure 7. Global Dry Eye Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Dry Eye Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dry Eye Drugs Revenue in 2023
    Figure 10. Dry Eye Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Artificial Tears Picture
    Figure 12. Anti-inflammatory Drugs Picture
    Figure 13. Other Picture
    Figure 14. Global Dry Eye Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Dry Eye Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Dry Eye Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Dry Eye Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Dry Eye Drugs Price by Type (2019-2030) & (USD/Unit)
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Drug Stores
    Figure 21. Product Picture of Online Pharmacies
    Figure 22. Global Dry Eye Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Dry Eye Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Dry Eye Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Dry Eye Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Dry Eye Drugs Price by Application (2019-2030) & (USD/Unit)
    Figure 27. North America Dry Eye Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Dry Eye Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Dry Eye Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Dry Eye Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Dry Eye Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Dry Eye Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Dry Eye Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Dry Eye Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Dry Eye Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Dry Eye Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Dry Eye Drugs Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Dry Eye Drugs Sales Volume (%), (2019-2030)
    Figure 39. United States Dry Eye Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Dry Eye Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Dry Eye Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Dry Eye Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Dry Eye Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Dry Eye Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Dry Eye Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Dry Eye Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Dry Eye Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Dry Eye Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Dry Eye Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Dry Eye Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Dry Eye Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Dry Eye Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Dry Eye Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 60. Dry Eye Drugs Industrial Chain
    Figure 61. Dry Eye Drugs Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS